A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease

Thyroid. 2024 Jan;34(1):134-137. doi: 10.1089/thy.2023.0466. Epub 2023 Dec 27.

Authors

Raymond S Douglas¹, Emanuil Parunakian¹, Joseph Tolentino¹, Emil Malkhasyan¹, June Geng¹, Michele Sherman², Shoaib Ugradar¹

Affiliations

¹ Department of Orbital and Oculoplastic Surgery, Private Practice, Beverly Hills, California, USA.
² Department of Audiology, The Towers, Audiology Center, Cedars Sinai Medical Center, Los Angeles, California, USA.

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Graves Ophthalmopathy* / drug therapy
Humans
Prospective Studies

Substances

teprotumumab
Antibodies, Monoclonal, Humanized